Pathogenic role of IgA receptors in IgA nephropathy
- PMID: 17495439
- DOI: 10.1159/000102306
Pathogenic role of IgA receptors in IgA nephropathy
Abstract
The pathogenesis of IgA nephropathy (IgAN) involves the deposition of aberrant glycosylated IgA1 and/or of IgA1-immune complexes (IC) in the glomerular mesangium. The mechanisms involved in the generation of IgA1-IC and how they are deposited in the mesangium are just emerging. We propose a model whereby two types of IgA receptors participate in sequential steps to promote the development of IgAN, with soluble FcalphaRI (CD89) being initially involved in the formation and/or amplification of the size of circulating IgAIC and, subsequently, transferrin receptor (CD71), in mediating mesangial deposition of nephritogenic IgA1-IC. Activation of transmembrane FcalphaRI associated with FcRgamma adaptor following interaction with IgA-IC is involved in aggravation of IgAN through induction of leukocyte infiltration. Taken together, understanding of the role of IgA receptors in physiology and physiopathology will open new avenues for therapeutic strategies in IgAN.
Similar articles
-
Role of IgA receptors in the pathogenesis of IgA nephropathy.J Nephrol. 2016 Feb;29(1):5-11. doi: 10.1007/s40620-015-0246-5. Epub 2015 Nov 14. J Nephrol. 2016. PMID: 26572664 Review.
-
Pathogenic significance of IgA receptor interactions in IgA nephropathy.Trends Mol Med. 2002 Oct;8(10):464-8. doi: 10.1016/s1471-4914(02)02405-x. Trends Mol Med. 2002. PMID: 12383768 Review.
-
New insights in the pathogenesis of IgA nephropathy.Nefrologia. 2005;25 Suppl 2:82-6. Nefrologia. 2005. PMID: 16050408
-
The glomerular response to IgA deposition in IgA nephropathy.Semin Nephrol. 2008 Jan;28(1):88-95. doi: 10.1016/j.semnephrol.2007.10.010. Semin Nephrol. 2008. PMID: 18222350 Review.
-
Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.J Exp Med. 2000 Jun 5;191(11):1999-2009. doi: 10.1084/jem.191.11.1999. J Exp Med. 2000. PMID: 10839814 Free PMC article.
Cited by
-
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.Semin Nephrol. 2008 Jan;28(1):78-87. doi: 10.1016/j.semnephrol.2007.10.009. Semin Nephrol. 2008. PMID: 18222349 Free PMC article. Review.
-
Update on immunoglobulin A nephropathy, Part I: Pathophysiology.World J Nephrol. 2015 Sep 6;4(4):455-67. doi: 10.5527/wjn.v4.i4.455. World J Nephrol. 2015. PMID: 26380197 Free PMC article.
-
New insights into the pathogenesis of IgA nephropathy.Semin Immunopathol. 2014 Jul;36(4):431-42. doi: 10.1007/s00281-013-0411-7. Epub 2014 Jan 18. Semin Immunopathol. 2014. PMID: 24442210 Review.
-
New Insights into the Pathogenesis of IgA Nephropathy.Kidney Dis (Basel). 2015 May;1(1):8-18. doi: 10.1159/000382134. Epub 2015 May 1. Kidney Dis (Basel). 2015. PMID: 26568951 Free PMC article.
-
Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis.BBA Clin. 2016 Feb 17;5:79-84. doi: 10.1016/j.bbacli.2016.02.002. eCollection 2016 Jun. BBA Clin. 2016. PMID: 27051593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous